Waller DA - Search Results

1

The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC.

Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. Ohri CM, et al. Among authors: waller da. PLoS One. 2011;6(7):e21874. doi: 10.1371/journal.pone.0021874. Epub 2011 Jul 22. PLoS One. 2011. PMID: 21799753 Free PMC article.

2

Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival.

Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. Ohri CM, et al. Among authors: waller da. Eur Respir J. 2009 Jan;33(1):118-26. doi: 10.1183/09031936.00065708. Eur Respir J. 2009. PMID: 19118225 Free article.

3

Mast cell phenotype, TNFα expression and degranulation status in non-small cell lung cancer.

Shikotra A, Ohri CM, Green RH, Waller DA, Bradding P. Shikotra A, et al. Among authors: waller da. Sci Rep. 2016 Dec 6;6:38352. doi: 10.1038/srep38352. Sci Rep. 2016. PMID: 27922077 Free PMC article.

4

Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.

Welsh TJ, Green RH, Richardson D, Waller DA, O'Byrne KJ, Bradding P. Welsh TJ, et al. Among authors: waller da. J Clin Oncol. 2005 Dec 10;23(35):8959-67. doi: 10.1200/JCO.2005.01.4910. Epub 2005 Oct 11. J Clin Oncol. 2005. PMID: 16219934

5

Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer.

Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. Ohri CM, et al. Among authors: waller da. BMC Cancer. 2010 Apr 29;10:172. doi: 10.1186/1471-2407-10-172. BMC Cancer. 2010. PMID: 20429924 Free PMC article.

6

Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer.

Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. Ohri CM, et al. Among authors: waller da. BMC Cancer. 2010 Jun 23;10:323. doi: 10.1186/1471-2407-10-323. BMC Cancer. 2010. PMID: 20573209 Free PMC article.

7

The N2 paradox: similar outcomes of pre- and postoperatively identified single-zone N2a positive non-small-cell lung cancer.

Tsitsias T, Boulemden A, Ang K, Nakas A, Waller DA. Tsitsias T, et al. Among authors: waller da. Eur J Cardiothorac Surg. 2014 May;45(5):882-7. doi: 10.1093/ejcts/ezt478. Epub 2013 Sep 29. Eur J Cardiothorac Surg. 2014. PMID: 24080282

8

EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma.

Edwards JG, Swinson DE, Jones JL, Waller DA, O'Byrne KJ. Edwards JG, et al. Among authors: waller da. Lung Cancer. 2006 Dec;54(3):399-407. doi: 10.1016/j.lungcan.2006.08.012. Epub 2006 Oct 17. Lung Cancer. 2006. PMID: 17049671

9

A biological staging model for operable non-small cell lung cancer.

Cox G, Jones JL, Andi A, Waller DA, O'Byrne KJ. Cox G, et al. Among authors: waller da. Thorax. 2001 Jul;56(7):561-6. doi: 10.1136/thorax.56.7.561. Thorax. 2001. PMID: 11413356 Free PMC article.

10

Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile?

Balduyck B, Trousse D, Nakas A, Martin-Ucar AE, Edwards J, Waller DA. Balduyck B, et al. Among authors: waller da. Ann Thorac Surg. 2010 Mar;89(3):907-11. doi: 10.1016/j.athoracsur.2009.12.041. Ann Thorac Surg. 2010. PMID: 20172152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters